Gaëtan Jego
6PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 21, 2024
First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphoma.Vincent Cabaud Gibouin, Manon Durand, Christophe Boudesco
|Feb 11, 2023
Heat-Shock Proteins in Leukemia and Lymphoma: Multitargets for Innovative Therapeutic Approaches.Vincent Cabaud-Gibouin, Manon Durand, Ronan Quéré
|Oct 03, 2020
XPO1E571K Mutation Modifies Exportin 1 Localisation and Interactome in B-cell Lymphoma.Hadjer Miloudi, Élodie Bohers, François Guillonneau
|Sep 16, 2020
Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms.Steven De Almeida, Mathilde Regimbeau, Gaëtan Jego
|Dec 22, 2019
Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy.Gaëtan Jego, François Hermetet, François Girodon
|Jun 07, 2018
HSP110 sustains chronic NF-κB signaling in activated B-cell diffuse large B-cell lymphoma through MyD88 stabilization.Christophe Boudesco, Els Verhoeyen, Laurent Martin
Pageof 1
